Receptor Holdings, Inc.
Pharmaceutical company · Seattle, Washington, United States
Receptor Holdings, Inc. is a pharmaceutical company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $7.3 million sold in a notice filed in 2021.
Receptor Holdings at a glance
What does Receptor Holdings do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $7.3 million sold (2021).
Frequently asked questions about Receptor Holdings
Where is Receptor Holdings headquartered?
Receptor Holdings, Inc. is headquartered in Seattle, Washington, United States.
What does Receptor Holdings do?
Receptor Holdings, Inc. is a pharmaceutical company.
When was Receptor Holdings founded?
The earliest incorporation on record for Receptor Holdings, Inc. is in 2018, according to public company registers.
Similar companies
- Omeros CorpSeattle, Washington, United States
- Chinook Therapeutics, Inc.Seattle, Washington, United States
- Cti Biopharma CorpSeattle, Washington, United States
- Perspective Therapeutics, Inc.Seattle, Washington, United States
- Aptevo Therapeutics Inc.Seattle, Washington, United States
- IPI Legacy Liquidation CoSeattle, Washington, United States
- Atossa Therapeutics, Inc.Seattle, Washington, United States
- Alpine Immune Sciences, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences